PMID- 29475928 OWN - NLM STAT- MEDLINE DCOM- 20180827 LR - 20181113 IS - 1791-7549 (Electronic) IS - 0258-851X (Print) IS - 0258-851X (Linking) VI - 32 IP - 2 DP - 2018 Mar-Apr TI - Tear Film Osmolarity in Subjects with Acute Allergic Rhinoconjunctivitis. PG - 403-408 AB - BACKGROUND/AIM: Acute allergic rhinoconjuctivitis is the most common form of ocular allergies. The pathogenetic mechanisms are based on an immunoglobulin E (IgE)-mediated hypersensitivity reaction. On the other hand, tear osmolarity has been suggested to be an index of ocular surface damage and inflammation. These data were the motive to investigate the levels of tear osmolarity in subjects with acute allergic rhinoconjuctivitis, before and after administration of artificial tears. PATIENTS AND METHODS: Forty-five subjects with acute allergic rhinoconjuctivitis were randomly divided into three groups, based on the type of artificial tears that they received: Group A (Thera tears), Group B (Wet therapy) and Group C (Tears Naturale free). The eye drops were administered six times a day for 60 days and all subjects underwent grading of subjective symptoms and clinical examination at baseline and at the end of the treatment. RESULTS: The diagnosis of severe eye disease, which was based on ocular surface disease index (OSDI; Allergan, Inc, Irvine, CA, USA) and tear osmolarity values, concerned all patients at baseline. Although the administration of artificial tears significantly ameliorated the symptoms and the ocular variables in all groups, the results were better in the first group. Tear osmolarity was strongly and negatively correlated with tear film breakup time (BUT) and Schirmer I test at 2 months. Contrariwise, symptoms were eliminated, when tear osmolarity was decreased. CONCLUSION: Acute allergic rhinoconjuctivitis is characterized by tear hyperosmolarity, which can be rehabilitated with the administration of hypotonic artificial tears. CI - Copyright(c) 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. FAU - Nitoda, Eirini AU - Nitoda E AD - First Department of Ophthalmology, General Hospital of Athens G. Gennimatas, Medical School, National and Kapodistrian University of Athens, Athens, Greece. FAU - Lavaris, Anastasios AU - Lavaris A AD - First Department of Ophthalmology, General Hospital of Athens G. Gennimatas, Medical School, National and Kapodistrian University of Athens, Athens, Greece. FAU - Laios, Konstantinos AU - Laios K AD - First Department of Ophthalmology, General Hospital of Athens G. Gennimatas, Medical School, National and Kapodistrian University of Athens, Athens, Greece. FAU - Androudi, Sophia AU - Androudi S AD - Department of Ophthalmology, University of Thessaly, Larissa, Greece. FAU - Kalogeropoulos, Chris D AU - Kalogeropoulos CD AD - Department of Ophtalmology, Medical School, University of Ioannina, Ioannina, Greece. FAU - Tsatsos, Michael AU - Tsatsos M AD - Department of Ophthalmology, University Hospital Southampton, Southampton, U.K. FAU - Damaskos, Christos AU - Damaskos C AD - Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece. AD - N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, Athens, Greece. FAU - Garmpis, Nikolaos AU - Garmpis N AD - Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece. AD - N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, Athens, Greece. FAU - Moschos, Marilita M AU - Moschos MM AD - First Department of Ophthalmology, General Hospital of Athens G. Gennimatas, Medical School, National and Kapodistrian University of Athens, Athens, Greece moschosmarilita@yahoo.fr. LA - eng PT - Journal Article PL - Greece TA - In Vivo JT - In vivo (Athens, Greece) JID - 8806809 SB - IM MH - Acute Disease MH - Adult MH - Conjunctivitis, Allergic/*immunology/*metabolism MH - Humans MH - Middle Aged MH - *Osmolar Concentration MH - Rhinitis, Allergic/*immunology/*metabolism MH - Tears/*chemistry PMC - PMC5905213 OTO - NOTNLM OT - Acute allergic rhinoconjuctivitis OT - artificial tears OT - tear osmolarity EDAT- 2018/02/25 06:00 MHDA- 2018/08/28 06:00 PMCR- 2018/03/03 CRDT- 2018/02/25 06:00 PHST- 2017/12/05 00:00 [received] PHST- 2018/01/07 00:00 [revised] PHST- 2018/01/11 00:00 [accepted] PHST- 2018/02/25 06:00 [entrez] PHST- 2018/02/25 06:00 [pubmed] PHST- 2018/08/28 06:00 [medline] PHST- 2018/03/03 00:00 [pmc-release] AID - 32/2/403 [pii] AID - 10.21873/invivo.11253 [doi] PST - ppublish SO - In Vivo. 2018 Mar-Apr;32(2):403-408. doi: 10.21873/invivo.11253.